Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/ncomms14381.

Title:
Neutrophils dominate the immune cell composition in non-small cell lung cancer | Nature Communications
Description:
The response rate to immune checkpoint inhibitor therapy for non-small-cell lung cancer (NSCLC) is just 20%. To improve this figure, several early phase clinical trials combining novel immunotherapeutics with immune checkpoint blockade have been initiated. Unfortunately, these trials have been designed without a strong foundational knowledge of the immune landscape present in NSCLC. Here, we use a flow cytometry panel capable of measuring 51 immune cell populations to comprehensively identify the immune cell composition and function in NSCLC. The results show that the immune cell composition is fundamentally different in lung adenocarcinoma as compared with lung squamous cell carcinoma, and that neutrophils are the most prevalent immune cell type. Using T-cell receptor-Ξ² sequencing and tumour reactivity assays, we predict that tumour reactive T cells are frequently present in NSCLC. These results should help to guide the design of clinical trials and the direction of future research in this area. Tumour immune evasion can involve multiple strategies. Here, the authors characterize the immune populations from clinical specimens of lung cancer in conjunction with TCR-Ξ² sequencing and show abundant neutrophils affecting cytotoxic T-cell content and the frequent presence of tumour-specific T-cell clones.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {πŸ“š}

  • Science
  • Telecommunications
  • Health & Fitness

Content Management System {πŸ“}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of nature.com audience?

πŸŒ† Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 41,362,249 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {πŸ’Έ}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {πŸ’°}


Display Ads {🎯}

$521,200 per month
Estimations show Nature.com's display ad online revenue falls between $347,485 and $955,583 per month.

Keywords {πŸ”}

cells, immune, cell, nsclc, tumour, lung, fig, cancer, article, data, ladca, tissue, lscca, supplementary, google, scholar, content, neutrophils, cas, performed, specimens, nature, composition, tcell, clonality, flow, cellular, size, cytometry, clinical, patients, analysis, present, correlation, study, function, populations, identify, tcrΞ², cases, til, versus, linear, clones, cohort, staining, monocytes, response, results, sequencing,

Topics {βœ’οΈ}

nature portfolio privacy policy ssc-height versus ssc-width advertising fluorochrome-conjugated anti-human antibodies t-cell media t-cell receptor-Ξ² sequencing accepted pro-host role 0/ reprints robust nature middle reciprocal nature t-cell receptor profiling l-adca versus l-scca author information authors t-cell content existed dominant t-cell populations cancer development future research bd cytofix/cytoperm kit small-cell lung cancer t-cell immunoglobulin domain combine anti-pd1 antibodies myeloid-derived suppressor cell nature 420 nature 489 nature 511 nature 515 nature 401 nature small-cell lung cancers cd8 t-cell exhaustion social media ccr7+cd45raβˆ’ central memory suppress t-cell proliferation tumour-specific mutation functioning combined tcr-Ξ² sequencing single-cell suspensions generated t-cell clonal expansion influence t-cell expansion tumour-infiltrating lymphocyte cultures matched tumour-normal pairs antigen-driven immune response influenced tcr-Ξ² clonality antigen-presenting cell features fluorochrome-conjugated antibodies myeloid-derived suppressor cells anti-pd1/pdl1 therapy1 anti-pd-l1 antibody ccr7βˆ’cd45raβˆ’ effector memory

Questions {❓}

  • Neutralizing tumour-promoting chronic inflammation: a magic bullet?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Neutrophils dominate the immune cell composition in non-small cell lung cancer
         description:The response rate to immune checkpoint inhibitor therapy for non-small-cell lung cancer (NSCLC) is just 20%. To improve this figure, several early phase clinical trials combining novel immunotherapeutics with immune checkpoint blockade have been initiated. Unfortunately, these trials have been designed without a strong foundational knowledge of the immune landscape present in NSCLC. Here, we use a flow cytometry panel capable of measuring 51 immune cell populations to comprehensively identify the immune cell composition and function in NSCLC. The results show that the immune cell composition is fundamentally different in lung adenocarcinoma as compared with lung squamous cell carcinoma, and that neutrophils are the most prevalent immune cell type. Using T-cell receptor-β sequencing and tumour reactivity assays, we predict that tumour reactive T cells are frequently present in NSCLC. These results should help to guide the design of clinical trials and the direction of future research in this area. Tumour immune evasion can involve multiple strategies. Here, the authors characterize the immune populations from clinical specimens of lung cancer in conjunction with TCR-β sequencing and show abundant neutrophils affecting cytotoxic T-cell content and the frequent presence of tumour-specific T-cell clones.
         datePublished:2017-02-01T00:00:00Z
         dateModified:2017-02-01T00:00:00Z
         pageStart:1
         pageEnd:11
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/ncomms14381
         keywords:
            Cancer microenvironment
            Non-small-cell lung cancer
            Tumour immunology
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms14381/MediaObjects/41467_2017_Article_BFncomms14381_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms14381/MediaObjects/41467_2017_Article_BFncomms14381_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms14381/MediaObjects/41467_2017_Article_BFncomms14381_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms14381/MediaObjects/41467_2017_Article_BFncomms14381_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms14381/MediaObjects/41467_2017_Article_BFncomms14381_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms14381/MediaObjects/41467_2017_Article_BFncomms14381_Fig6_HTML.jpg
         isPartOf:
            name:Nature Communications
            issn:
               2041-1723
            volumeNumber:8
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Julia Kargl
               affiliation:
                     name:Clinical Research Division
                     address:
                        name:Clinical Research Division, Seattle, USA
                        type:PostalAddress
                     type:Organization
                     name:Institute of Experimental and Clinical Pharmacology, Medical University of Graz
                     address:
                        name:Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stephanie E. Busch
               affiliation:
                     name:Clinical Research Division
                     address:
                        name:Clinical Research Division, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Grace H. Y. Yang
               affiliation:
                     name:Clinical Research Division
                     address:
                        name:Clinical Research Division, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kyoung-Hee Kim
               affiliation:
                     name:Clinical Research Division
                     address:
                        name:Clinical Research Division, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mark L. Hanke
               affiliation:
                     name:Clinical Research Division
                     address:
                        name:Clinical Research Division, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Heather E. Metz
               affiliation:
                     name:Clinical Research Division
                     address:
                        name:Clinical Research Division, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jesse J. Hubbard
               affiliation:
                     name:Clinical Research Division
                     address:
                        name:Clinical Research Division, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sylvia M. Lee
               affiliation:
                     name:Clinical Research Division
                     address:
                        name:Clinical Research Division, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David K. Madtes
               affiliation:
                     name:Clinical Research Division
                     address:
                        name:Clinical Research Division, Seattle, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Washington
                     address:
                        name:Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Martin W. McIntosh
               affiliation:
                     name:Fred Hutchinson Cancer Research Center
                     address:
                        name:Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A. McGarry Houghton
               affiliation:
                     name:Clinical Research Division
                     address:
                        name:Clinical Research Division, Seattle, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Washington
                     address:
                        name:Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, USA
                        type:PostalAddress
                     type:Organization
                     name:Human Biology Division
                     address:
                        name:Human Biology Division, Seattle, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Neutrophils dominate the immune cell composition in non-small cell lung cancer
      description:The response rate to immune checkpoint inhibitor therapy for non-small-cell lung cancer (NSCLC) is just 20%. To improve this figure, several early phase clinical trials combining novel immunotherapeutics with immune checkpoint blockade have been initiated. Unfortunately, these trials have been designed without a strong foundational knowledge of the immune landscape present in NSCLC. Here, we use a flow cytometry panel capable of measuring 51 immune cell populations to comprehensively identify the immune cell composition and function in NSCLC. The results show that the immune cell composition is fundamentally different in lung adenocarcinoma as compared with lung squamous cell carcinoma, and that neutrophils are the most prevalent immune cell type. Using T-cell receptor-β sequencing and tumour reactivity assays, we predict that tumour reactive T cells are frequently present in NSCLC. These results should help to guide the design of clinical trials and the direction of future research in this area. Tumour immune evasion can involve multiple strategies. Here, the authors characterize the immune populations from clinical specimens of lung cancer in conjunction with TCR-β sequencing and show abundant neutrophils affecting cytotoxic T-cell content and the frequent presence of tumour-specific T-cell clones.
      datePublished:2017-02-01T00:00:00Z
      dateModified:2017-02-01T00:00:00Z
      pageStart:1
      pageEnd:11
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/ncomms14381
      keywords:
         Cancer microenvironment
         Non-small-cell lung cancer
         Tumour immunology
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms14381/MediaObjects/41467_2017_Article_BFncomms14381_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms14381/MediaObjects/41467_2017_Article_BFncomms14381_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms14381/MediaObjects/41467_2017_Article_BFncomms14381_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms14381/MediaObjects/41467_2017_Article_BFncomms14381_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms14381/MediaObjects/41467_2017_Article_BFncomms14381_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms14381/MediaObjects/41467_2017_Article_BFncomms14381_Fig6_HTML.jpg
      isPartOf:
         name:Nature Communications
         issn:
            2041-1723
         volumeNumber:8
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Julia Kargl
            affiliation:
                  name:Clinical Research Division
                  address:
                     name:Clinical Research Division, Seattle, USA
                     type:PostalAddress
                  type:Organization
                  name:Institute of Experimental and Clinical Pharmacology, Medical University of Graz
                  address:
                     name:Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stephanie E. Busch
            affiliation:
                  name:Clinical Research Division
                  address:
                     name:Clinical Research Division, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Grace H. Y. Yang
            affiliation:
                  name:Clinical Research Division
                  address:
                     name:Clinical Research Division, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kyoung-Hee Kim
            affiliation:
                  name:Clinical Research Division
                  address:
                     name:Clinical Research Division, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mark L. Hanke
            affiliation:
                  name:Clinical Research Division
                  address:
                     name:Clinical Research Division, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Heather E. Metz
            affiliation:
                  name:Clinical Research Division
                  address:
                     name:Clinical Research Division, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jesse J. Hubbard
            affiliation:
                  name:Clinical Research Division
                  address:
                     name:Clinical Research Division, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sylvia M. Lee
            affiliation:
                  name:Clinical Research Division
                  address:
                     name:Clinical Research Division, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David K. Madtes
            affiliation:
                  name:Clinical Research Division
                  address:
                     name:Clinical Research Division, Seattle, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Washington
                  address:
                     name:Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Martin W. McIntosh
            affiliation:
                  name:Fred Hutchinson Cancer Research Center
                  address:
                     name:Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A. McGarry Houghton
            affiliation:
                  name:Clinical Research Division
                  address:
                     name:Clinical Research Division, Seattle, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Washington
                  address:
                     name:Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, USA
                     type:PostalAddress
                  type:Organization
                  name:Human Biology Division
                  address:
                     name:Human Biology Division, Seattle, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Nature Communications
      issn:
         2041-1723
      volumeNumber:8
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Clinical Research Division
      address:
         name:Clinical Research Division, Seattle, USA
         type:PostalAddress
      name:Institute of Experimental and Clinical Pharmacology, Medical University of Graz
      address:
         name:Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria
         type:PostalAddress
      name:Clinical Research Division
      address:
         name:Clinical Research Division, Seattle, USA
         type:PostalAddress
      name:Clinical Research Division
      address:
         name:Clinical Research Division, Seattle, USA
         type:PostalAddress
      name:Clinical Research Division
      address:
         name:Clinical Research Division, Seattle, USA
         type:PostalAddress
      name:Clinical Research Division
      address:
         name:Clinical Research Division, Seattle, USA
         type:PostalAddress
      name:Clinical Research Division
      address:
         name:Clinical Research Division, Seattle, USA
         type:PostalAddress
      name:Clinical Research Division
      address:
         name:Clinical Research Division, Seattle, USA
         type:PostalAddress
      name:Clinical Research Division
      address:
         name:Clinical Research Division, Seattle, USA
         type:PostalAddress
      name:Clinical Research Division
      address:
         name:Clinical Research Division, Seattle, USA
         type:PostalAddress
      name:University of Washington
      address:
         name:Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, USA
         type:PostalAddress
      name:Fred Hutchinson Cancer Research Center
      address:
         name:Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA
         type:PostalAddress
      name:Clinical Research Division
      address:
         name:Clinical Research Division, Seattle, USA
         type:PostalAddress
      name:University of Washington
      address:
         name:Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, USA
         type:PostalAddress
      name:Human Biology Division
      address:
         name:Human Biology Division, Seattle, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Julia Kargl
      affiliation:
            name:Clinical Research Division
            address:
               name:Clinical Research Division, Seattle, USA
               type:PostalAddress
            type:Organization
            name:Institute of Experimental and Clinical Pharmacology, Medical University of Graz
            address:
               name:Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria
               type:PostalAddress
            type:Organization
      name:Stephanie E. Busch
      affiliation:
            name:Clinical Research Division
            address:
               name:Clinical Research Division, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Grace H. Y. Yang
      affiliation:
            name:Clinical Research Division
            address:
               name:Clinical Research Division, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Kyoung-Hee Kim
      affiliation:
            name:Clinical Research Division
            address:
               name:Clinical Research Division, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Mark L. Hanke
      affiliation:
            name:Clinical Research Division
            address:
               name:Clinical Research Division, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Heather E. Metz
      affiliation:
            name:Clinical Research Division
            address:
               name:Clinical Research Division, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Jesse J. Hubbard
      affiliation:
            name:Clinical Research Division
            address:
               name:Clinical Research Division, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Sylvia M. Lee
      affiliation:
            name:Clinical Research Division
            address:
               name:Clinical Research Division, Seattle, USA
               type:PostalAddress
            type:Organization
      name:David K. Madtes
      affiliation:
            name:Clinical Research Division
            address:
               name:Clinical Research Division, Seattle, USA
               type:PostalAddress
            type:Organization
            name:University of Washington
            address:
               name:Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Martin W. McIntosh
      affiliation:
            name:Fred Hutchinson Cancer Research Center
            address:
               name:Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA
               type:PostalAddress
            type:Organization
      name:A. McGarry Houghton
      affiliation:
            name:Clinical Research Division
            address:
               name:Clinical Research Division, Seattle, USA
               type:PostalAddress
            type:Organization
            name:University of Washington
            address:
               name:Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, USA
               type:PostalAddress
            type:Organization
            name:Human Biology Division
            address:
               name:Human Biology Division, Seattle, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Clinical Research Division, Seattle, USA
      name:Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria
      name:Clinical Research Division, Seattle, USA
      name:Clinical Research Division, Seattle, USA
      name:Clinical Research Division, Seattle, USA
      name:Clinical Research Division, Seattle, USA
      name:Clinical Research Division, Seattle, USA
      name:Clinical Research Division, Seattle, USA
      name:Clinical Research Division, Seattle, USA
      name:Clinical Research Division, Seattle, USA
      name:Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, USA
      name:Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA
      name:Clinical Research Division, Seattle, USA
      name:Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, USA
      name:Human Biology Division, Seattle, USA

External Links {πŸ”—}(135)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Prism.js
  • Zoom.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {πŸ“¦}

  • Crossref

5.29s.